Legal & General Group Plc Acquires 60,817 Shares of Azenta, Inc. (NASDAQ:AZTA)

Legal & General Group Plc increased its position in shares of Azenta, Inc. (NASDAQ:AZTA - Free Report) by 17.5% during the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 408,484 shares of the company's stock after acquiring an additional 60,817 shares during the quarter. Legal & General Group Plc owned about 0.89% of Azenta worth $20,424,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Invesco Ltd. boosted its stake in shares of Azenta by 39.3% in the 4th quarter. Invesco Ltd. now owns 218,795 shares of the company's stock valued at $10,940,000 after purchasing an additional 61,678 shares during the last quarter. Bank of Montreal Can lifted its holdings in Azenta by 17.4% in the fourth quarter. Bank of Montreal Can now owns 9,097 shares of the company's stock valued at $455,000 after buying an additional 1,350 shares during the period. Federated Hermes Inc. boosted its stake in Azenta by 65.9% in the fourth quarter. Federated Hermes Inc. now owns 762,189 shares of the company's stock valued at $38,109,000 after acquiring an additional 302,786 shares during the last quarter. Russell Investments Group Ltd. grew its holdings in Azenta by 195.3% during the 4th quarter. Russell Investments Group Ltd. now owns 12,904 shares of the company's stock worth $645,000 after acquiring an additional 8,534 shares during the period. Finally, Landscape Capital Management L.L.C. acquired a new position in shares of Azenta in the 4th quarter valued at $217,000. 99.08% of the stock is currently owned by institutional investors and hedge funds.

Remove Ads

Azenta Trading Down 6.2 %

Shares of Azenta stock traded down $1.71 during trading on Tuesday, reaching $25.91. The stock had a trading volume of 788,200 shares, compared to its average volume of 634,823. The company has a market capitalization of $1.18 billion, a price-to-earnings ratio of -8.69 and a beta of 1.66. Azenta, Inc. has a 52 week low of $25.36 and a 52 week high of $63.58. The stock has a fifty day moving average price of $38.34 and a two-hundred day moving average price of $44.44.

Azenta (NASDAQ:AZTA - Get Free Report) last issued its quarterly earnings results on Wednesday, February 5th. The company reported $0.08 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.05 by $0.03. Azenta had a negative net margin of 24.91% and a positive return on equity of 1.25%. On average, equities analysts forecast that Azenta, Inc. will post 0.53 EPS for the current fiscal year.

Analyst Ratings Changes

AZTA has been the subject of a number of recent analyst reports. Stephens reiterated an "overweight" rating and issued a $60.00 price objective on shares of Azenta in a report on Thursday, January 2nd. Evercore ISI lifted their price objective on shares of Azenta from $50.00 to $52.00 and gave the stock an "in-line" rating in a research note on Thursday, February 6th. TD Cowen upgraded shares of Azenta to a "hold" rating in a report on Thursday, February 27th. Finally, Needham & Company LLC increased their target price on shares of Azenta from $55.00 to $59.00 and gave the stock a "buy" rating in a report on Thursday, February 6th.

Azenta Company Profile

Azenta, Inc provides biological and chemical compound sample exploration and management solutions for the life sciences market in North America, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. The company operates in two reportable segments, Life Sciences Products and Life Sciences Services.